Morgan Stanley Maintains Gilead at ‘Equalweight’ with Price Target of $88.00
🌥️Trending News Gilead Sciences ($NASDAQ:GILD), Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapeutics for the [...]
Gilead Sciences’ Price Over Earnings Overview Revealed
🌥️Trending News Gilead Sciences ($NASDAQ:GILD) is a leading biopharmaceutical company that focuses on developing treatments for life-threatening diseases. It is [...]
Zacks Research Increases Gilead Sciences’ FY2024 Earnings Per Share Estimates
☀️Trending News Gilead Sciences ($NASDAQ:GILD), Inc. is a biopharmaceutical company based in Foster City, California. It is focused on developing [...]
Gilead Sciences Intrinsic Value Calculation – Gilead Sciences Boosts AlloVir Stake, Shares Soar 11% in Pre-Market Trading
☀️Trending News Gilead Sciences ($NASDAQ:GILD) is a biotechnology company that has invested heavily in the development of groundbreaking treatments for [...]
Gilead Sciences Intrinsic Value Calculation – Investors in Gilead Sciences Reap 28% Return in Just One Year!
🌥️Trending News Investors in Gilead Sciences ($NASDAQ:GILD) have been reaping the rewards over the past year with a 28% return [...]
Gilead Sciences Stock Intrinsic Value – Gilead Sciences: A Pharma Stock to Watch Amid Multiple ASCO Data Readouts
🌥️Trending News Gilead Sciences ($NASDAQ:GILD), Inc. is an American biotechnology company that focuses on developing treatments for life-threatening diseases. In [...]
Polaris Capital Management LLC Increases Stake in Gilead Sciences, by 1.5% in Fourth Quarter.
Trending News 🌥️ Gilead Sciences ($NASDAQ:GILD), Inc. is a biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for [...]
EMA Approves Gilead Sciences’ Vemlidy for Use in Children Above 6 with Hepatitis B
Trending News ☀️ Gilead Sciences ($NASDAQ:GILD), Inc. is an American biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance [...]
Gilead Sciences Stock Fair Value Calculator – Gilead Sciences’ Outlook Dimmed Following Rating Downgrade
Trending News 🌥️ Gilead Sciences ($NASDAQ:GILD), a leading biopharmaceutical company, has seen its outlook dimmed following a recent rating downgrade. [...]
GILEAD SCIENCES Announces Fiscal Year 2022 Fourth Quarter Earnings Results on February 2, 2023.
Earnings Overview On February 2, 2023, GILEAD SCIENCES ($NASDAQ:GILD) reported their fourth quarter earnings results for the fiscal year 2022, [...]
